Peptide ADME Optimization Service
Peptide ADME Optimization Service
Peptide ADME Optimization Service is a specialized drug development support platform focused on improving the pharmacokinetic and pharmacodynamic properties of peptide-based therapeutics. ADME—absorption, distribution, metabolism, and excretion—is a critical determinant of whether a peptide candidate can successfully progress from early discovery to clinical application. Although peptides often demonstrate high target specificity and low toxicity, their clinical translation is frequently limited by rapid enzymatic degradation, poor oral bioavailability, and short systemic half-life.
This service addresses these challenges through integrated experimental and computational optimization strategies designed to enhance peptide stability, bioavailability, and overall drug-likeness.
Absorption Optimization Strategies
Peptides typically exhibit limited absorption due to their size, polarity, and susceptibility to gastrointestinal degradation. The ADME optimization workflow explores multiple strategies to improve absorption efficiency depending on the intended route of administration.
For systemic delivery, modifications may focus on enhancing membrane permeability and transport efficiency. For non-intravenous routes, such as oral or transdermal delivery, strategies may include backbone modification, cyclization, or formulation-based approaches that improve epithelial transport and reduce enzymatic breakdown.
These approaches aim to increase the fraction of active peptide reaching systemic circulation while maintaining biological activity and target specificity.
